IHT Wealth Management’s Novavax NVAX Stock Holding History

IHT Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-997	Closed	-$212K	–	924
2021 Q2	$212K	Sell	997 -260	-21%	-$47.6K	0.01%	850
2021 Q1	$228K	Buy	1,257 +1,192	+1,834%	+$238K	0.02%	723
2020 Q4	$265K	Sell	65 -3,078	-98%	-$327K	0.02%	600
2020 Q3	$595K	Sell	3,143 -4,755	-60%	-$579K	0.06%	308
2020 Q2	$658K	Buy	+7,898	New	+$302K	0.09%	232
2019 Q2	–	Sell	-11,693	Closed	-$129K	–	559
2019 Q1	$129K	Buy	11,693 +85	+0.7%	+$2.68K	0.02%	487
2018 Q4	$427K	Buy	11,608 +82	+0.7%	+$3.18K	0.08%	268
2018 Q3	$433K	Hold	11,526	–	–	0.09%	249
2018 Q2	$309K	Sell	11,526 -376	-3%	-$12.7K	0.08%	297
2018 Q1	$507K	Sell	11,902 -205	-2%	-$8.24K	0.14%	181
2017 Q4	$327K	Buy	+12,107	New	+$295K	0.09%	272

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IHT Wealth Management's NVAX Position: Q3 2021 in Review

IHT Wealth Management sold out of Novavax (NVAX) in Q3 2021, closing a stake of 997 shares — an estimated $212K sold.

IHT Wealth Management first reported a position in NVAX in Q4 2017 and held it in 11 quarters. The position peaked at $658K in Q2 2020. 442 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

IHT Wealth Management reported no remaining Novavax position as of Q3 2021 after selling out during the quarter.
IHT Wealth Management sold 997 Novavax shares in Q3 2021, an estimated $212K.
IHT Wealth Management first reported a position in Novavax in Q4 2017 and held it in 11 quarters.
IHT Wealth Management's Novavax position peaked at $658K in Q2 2020.
442 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on IHT Wealth Management's 13F filing for Q3 2021, filed 15 Nov 2021.